ABX 10241
Alternative Names: ABX-PTH; ABX10241; Human anti-parathyroid hormone monoclonal antibody; human anti-PTH monoclonal antibodyLatest Information Update: 10 Sep 2008
At a glance
- Originator Abgenix
- Class Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperparathyroidism
Most Recent Events
- 03 Apr 2006 Abgenix has been acquired and merged into Amgen
- 18 May 2005 ABX-10241 is available for ex-US licensing (http://www.abgenix.com)
- 11 May 2005 Enrolment into a phase I study is ongoing